Page 9 - Peter Stein News Today

FDA advisory panel recommends revoking sale of preterm birth drug

WASHINGTON (dpa-AFX) - A US Food and Drug Administration or FDA advisory committee voted on Wednesday that a drug approved more than ten years ago to bring down the risk of pre-term birth should

Makena is ineffective, argued FDA panel

An FDA panel recommends that a drug approved to prevent premature birth be removed from the market because it doesn't work and carries risks.

BioPharma

A US Food and Drug Administration advisory committee voted Wednesday that a drug approved more than a decade ago to reduce the risk of preterm birth should not be allowed

A U.S. Food and Drug Administration advisory committee voted Wednesday that a drug approved more than a decade ago to reduce the risk of preterm birth should not be allowed

The Swedish left’s denial of the problems of crime and anti-Semitism are the source of its electoral problems.

Since pharmaceutical companies started funding their FDA drug applications 30 years ago, the agency’s reviews have gone much faster — perhaps too fast.

Join Kathryn Bernheimer via Zoom for a sneak preview of the film festival on October 12 - then buy tickets.